Our Products
Our offered Product range includes Paclitaxel Injection, Letrozole Tablets, DOCETAXEL, Paclitaxel and Methotrexate Tablets.
CAS NO:33069-62-4
Paclitaxel is a cancer medication used to treat various types of cancer such as breast cancer, ovarian cancer, lung cancer, and a form of skin cancer such as Kaposi's sarcoma in people with AIDS.
Paclitaxel is a novel antimicrotubule agent that promotes the assembly of microtubules from tubulin dimers and stabilizes microtubules by preventing depolymerization.
It is also used for the prevention of restenosis.Paclitaxel injection is available in 30 mg, 60 mg and 100mg compositions.
Letrozole tablets USP 2.5 mg is used in the treatment of advanced breast cancer in women.
Letrozole is the second in a new class of third-generation selective oral aromatase inhibitors. It acts by blocking the enzyme aromatase, subsequently blocking the production of estrogen.
The recommended dose of Letrozole is 2.5 mg once daily, at the same time each day, taken with or without food.
CAS NO:59-05-2
Methotrexate 2.5 mg, 5 mg, 7.5 mg & 10 mg strengths are used for cancer treatment generally in higher doses than for other uses. It is used in maintenance therapy in combination with other chemotherapeutic agent.
It is used to treat psoriasis and also used to treat active rheumatoid arthritis in adults and children.
CAS NO:120511-73-1
Anastrozole is called non-steroidal aromatase inhibitors.Anastrozole tablets USP 1mg is used to treat breast cancer in women whose breast cancer has worsened after taking tamoxifen & who have experienced menopause .Anastrozole has been used for reducing estrogens, including estradiol, in men. Excess estradiol in men can cause benign prostatic hyperplasia, gynecomastia, and symptoms of hypogonadism, so it has been used to reduce and prevent symptoms of excess estrogens; gynecomastia and water retention.
CAS NO:114977-28-5
Docetaxel injection is available of 20mg/ 1ml composition.Our docetaxel injections are used for the treatment of cancer of Breast, Lung, Prostate, Stomach, Head and neck, Ovarian, Gastric, Pancreatic and Hormone refractory cancer.
CAS NO: 109889-09-0
Granisetron is used to prevent nausea and vomiting caused by cancer chemotherapy and radiation therapy. Granisetron is in a class of medications called 5-HT3 antagonists. It works by blocking serotonin, a natural substance in the body that causes nausea and vomiting.
Granisetron comes as a tablet and a solution (liquid) to take by mouth. When taken to prevent nausea and vomiting caused by chemotherapy, granisetron is usually taken 1 hour before chemotherapy is begun. A second dose may be taken 12 hours after the first dose. When taken to prevent nausea and vomiting caused by radiation, granisetron is usually taken within 1 hour before treatment.